Companies
Discover all trending biotech companies
Discover all trending biotech companies
Company Research Platform
Annual Revenue
$ 359,000,000,000
Global Employees
45,000
R&D Investment
89000000
This segment focuses on the distribution of branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. It provides comprehensive services to pharmacies, including practice management, technology, clinical support, and business solutions. Research and development efforts are directed towards optimizing supply chain efficiency, enhancing inventory management, and developing innovative solutions for community-based oncology and specialty practices. The segment leverages advanced data analytics and automation technologies to improve operational performance and ensure timely delivery of medications to patients. Future opportunities include expanding specialty pharmacy services and developing personalized medicine solutions.
The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. This includes a wide range of products, from basic medical supplies to advanced surgical equipment. The segment focuses on streamlining supply chain operations, reducing costs, and improving patient outcomes. Research and development activities are centered on developing innovative logistics solutions, enhancing product tracking and traceability, and improving inventory management. Technologies such as AI and machine learning are used to optimize supply chain efficiency and predict demand. Future opportunities include expanding into new markets and developing value-added services for healthcare providers.
The RxTS segment offers a suite of technology solutions designed to improve medication access, adherence, and affordability. This includes CoverMyMeds, which helps patients get the medications they need; RelayHealth, a workflow solution; RxCrossroads, which provides solutions for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology. Research and development efforts are focused on developing innovative digital health solutions, leveraging data analytics to improve patient outcomes, and enhancing pharmacy automation technologies. The segment aims to improve medication adherence, reduce healthcare costs, and enhance the patient experience. Future opportunities include expanding into new therapeutic areas and developing personalized medicine solutions.